Have an app you've always wanted to build? A humdrum task to automate? AI tools make it easier than ever, but they can be as ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

Despite only starting running in her mid-50s the sport has since taken 72-year-old Judith Porter all around the world. Some of her highlights? Representing England in her age group at the Manchester ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. The Blade Angels — a.k.a. the women of Team USA ...

In Oregon and Colorado, you can book an appointment for psilocybin therapy, where a licensed therapist takes you on a guided trip using the drug that makes “magic” mushrooms hallucinogenic. Host Flora ...

Work is full of time-sucking, tedious or annoying tasks, particularly when you’re on a computer. I used to spend hours on stupid chores like reorganizing someone else’s messy spreadsheet. Now, I use ...

Share on Facebook (opens in a new window) Share on X (opens in a new window) Share on Reddit (opens in a new window) Share on Hacker News (opens in a new window) Share on Flipboard (opens in a new ...

If a user opened this Markdown file in Windows 11 Notepad versions 11.2510 and earlier and viewed it in Markdown mode, the above text would appear as a clickable link. If the link is clicked with ...

Health Secretary Robert F. Kennedy Jr. said addiction is a “spiritual disease” that calls out for the involvement of religious organizations. By Ellen Barry Health Secretary Robert F. Kennedy Jr.

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.